KG
Kelsey Goodwin Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
47%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $14 |
8%
upside
| 1 | +37% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $30 |
118%
upside
| 1 | -23% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $11 |
14%
upside
| 2 | +82% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $70 |
28%
upside
| 1 | +53% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Overweight
Maintained
| $8 |
213%
upside
| 2 | -19% |
0
%
| 16 Jan ‘26 2 days ago |
|
|
|
Overweight
Initiated
| $24 |
379%
upside
| 1 | -2.1% |
0
%
| 7 Jan ‘26 11 days ago |
|
|
|
Overweight
Initiated
| $22 |
82%
upside
| 1 | +49% |
0
%
| 7 Jan ‘26 11 days ago |
|
|
|
Overweight
Maintained
| $26 |
156%
upside
| 1 | +39% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $128 |
23%
upside
| 1 | +18% |
0
%
| 27 Oct ‘25 2 months ago |
|